Foundry Partners, LLC Repligen Corp Transaction History

Foundry Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$114.17 - $185.35 $129,582 - $210,372	1,135 New	1,135 $204,000
Q1 2023 May 03, 2023	SELL	$154.26 - $198.1 $3,856 - $4,952	-25 Reduced 1.53%	1,604 $270,000
Q3 2022 Oct 21, 2022	BUY	$160.42 - $256.21 $261,324 - $417,366	1,629 New	1,629 $305,000
Q2 2022 Jul 28, 2022	SELL	$140.68 - $188.02 $170,082 - $227,316	-1,209 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$161.19 - $257.96 $6,769 - $10,834	42 Added 3.6%	1,209 $227,000
Q3 2021 Oct 14, 2021	BUY	$194.77 - $324.21 $227,296 - $378,353	1,167 New	1,167 $337,000
Q2 2021 Jul 23, 2021	SELL	$165.87 - $220.95 $1.37 Million - $1.83 Million	-8,271 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$180.37 - $226.26 $637,427 - $799,602	-3,534 Reduced 29.94%	8,271 $1.61 Million
Q4 2020 Feb 04, 2021	SELL	$148.08 - $206.57 $8,736 - $12,187	-59 Reduced 0.5%	11,805 $2.26 Million
Q3 2020 Oct 23, 2020	BUY	$122.51 - $158.27 $68,850 - $88,947	562 Added 4.97%	11,864 $1.75 Million
Q2 2020 Aug 03, 2020	SELL	$94.33 - $140.48 $41,033 - $61,108	-435 Reduced 3.71%	11,302 $1.4 Million
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $997,175 - $1.28 Million	11,737 New	11,737 $1.13 Million
Q4 2017 Jan 25, 2018	SELL	$32.53 - $38.92 $2.54 Million - $3.03 Million	-77,969 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$36.98 - $46.06 $2.88 Million - $3.59 Million	77,969	77,969 $2.99 Million

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.32B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.